Search research articles
Contact Us
Filters
Showing results (51-60 of 311) with videos related to
Page
of 32
Sort By:
Cancers
|
June 28, 2019
Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients
Maoshan Chen, Sridurga Mithraprabhu, Malarmathy Ramachandran, et al.
Frontiers in Oncology
|
June 6, 2022
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
Rose Turner, Anna Kalff, Krystal Bergin, et al.
Molecular Cancer Therapeutics
|
May 14, 2017
β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma
Ioanna Savvidou, Tiffany Khong, Andrew Cuddihy, et al.
Leukemia & Lymphoma
|
December 4, 2020
Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature
Gemma Reynolds, Tamasine Stewart, Simon J Harrison, et al.
British Journal of Haematology
|
July 26, 2002
Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk
Ian Kerridge, Lisa Lincz, Fiona Scorgie, et al.
Nanoscale Advances
|
March 2, 2026
Raised or recessed? Finding the optimal gate architecture for improving the static performance of graphene transistors
Tzu-Jung Huang, Andrew Spencer, Luke Ingraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients
Chindu Govindaraj, Peter Tan, Patricia Walker, et al.
British Journal of Haematology
|
April 8, 2026
HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myeloma
Elizabeth Hughes, Piers Blombery, Sushmitha Kannan, et al.
Critical Reviews in Oncology/Hematology
|
February 1, 2022
A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy
John Coutsouvelis, Carmela Corallo, Andrew Spencer, et al.
Leukemia Research
|
September 26, 2006
Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma
Cindy Baulch-Brown, Timothy J Molloy, Sung Lin Yeh, et al.
Page
of 32
Search research articles
Search
Showing results (51-60 of 311) with videos related to
Sort By:
Page
of 32
Cancers
|
June 28, 2019
Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients
Maoshan Chen, Sridurga Mithraprabhu, Malarmathy Ramachandran, et al.
Frontiers in Oncology
|
June 6, 2022
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
Rose Turner, Anna Kalff, Krystal Bergin, et al.
Molecular Cancer Therapeutics
|
May 14, 2017
β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma
Ioanna Savvidou, Tiffany Khong, Andrew Cuddihy, et al.
Leukemia & Lymphoma
|
December 4, 2020
Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature
Gemma Reynolds, Tamasine Stewart, Simon J Harrison, et al.
British Journal of Haematology
|
July 26, 2002
Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk
Ian Kerridge, Lisa Lincz, Fiona Scorgie, et al.
Nanoscale Advances
|
March 2, 2026
Raised or recessed? Finding the optimal gate architecture for improving the static performance of graphene transistors
Tzu-Jung Huang, Andrew Spencer, Luke Ingraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients
Chindu Govindaraj, Peter Tan, Patricia Walker, et al.
British Journal of Haematology
|
April 8, 2026
HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myeloma
Elizabeth Hughes, Piers Blombery, Sushmitha Kannan, et al.
Critical Reviews in Oncology/Hematology
|
February 1, 2022
A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy
John Coutsouvelis, Carmela Corallo, Andrew Spencer, et al.
Leukemia Research
|
September 26, 2006
Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma
Cindy Baulch-Brown, Timothy J Molloy, Sung Lin Yeh, et al.
Page
of 32